Trial Profile
Randomized, Double-Blind, Placebo-Controlled, Phase II Trial Of Short Course Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized (3.5 to 7cm) Hepatocellular Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2023
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Jul 2021 Primary endpoint (Coagulation Zone Volume) has not been met, according to Results published in the Digestive Diseases and Sciences.
- 23 Jul 2021 Primary endpoint (Coagulation Zone Diameter-Long Axis) has not been met.according to Results published in the Digestive Diseases and Sciences.
- 23 Jul 2021 Primary endpoint (Coagulation Zone Diameter-Short Axis) has not been met, according to Results published in the Digestive Diseases and Sciences.